Heterogeneity and clinical significance of ESR1 mutations in ER-positive metastatic breast cancer patients receiving fulvestrant
暂无分享,去创建一个
G. Hampton | K. Walter | T. Wilson | J. Spoerke | L. Amler | S. Johnston | Meng Chen | P. Schmid | M. Lackner | M. Derynck | I. Krop | J. Qiu | S. Gendreau | J. Aimi | I. Chan | H. Savage | Iris T. Chan | T. Wilson